Thymosin Alpha-1
Also: TA-1 · Zadaxin
Immune modulator — used clinically for chronic viral infections and immune support.
Evidence
established
Legal status
approved some regions
Half-life
~2 hours
Routes
subq
What it is
Thymosin Alpha-1 is approved in dozens of countries for chronic hepatitis B and adjunct cancer therapy. It modulates rather than stimulates the immune system, making it useful in both deficient and overactive immune states.
Mechanism
28-amino-acid peptide that modulates T-cell maturation and immune balance.
Outcomes it's matched to
- STRENGTH70%
- STRENGTH60%
- STRENGTH55%
Safety
Very well tolerated. Mild injection-site reactions most common.
- Immunosuppressed transplant patients
Legal context
Approved in 30+ countries; not FDA-approved in the US.